Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

Cencora, Inc. (COR) Free Cash Flow Yield: 2.83%

Is Cencora, Inc.’s free cash flow yield high or low?

Cencora, Inc.'s free cash flow yield of 2.83% is 57% below its 5-year average of 6.59%, near the low end of its 5-year range (1.57%–10.50%).

As of Saturday, June 13, 2026. 30.62% below its 12-month average of 4.08%.

COR Free Cash Flow Yield Chart

COR Free Cash Flow Yield
2.83%-54.43% 1Y
Zoom

COR Average Free Cash Flow Yield Chart

COR Current vs Average Free Cash Flow Yield Chart

COR Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

2.83%

FREE CASH FLOW YIELD AVG TTM

4.08%

FREE CASH FLOW YIELD AVG 3Y

5.93%

FREE CASH FLOW YIELD AVG 5Y

6.59%

FREE CASH FLOW YIELD AVG 10Y

7.91%

FREE CASH FLOW YIELD AVG 15Y

8.70%

FREE CASH FLOW YIELD AVG 20Y

8.82%

CURRENT VS TTM AVG

-30.62%

CURRENT VS 3Y AVG

-52.27%

CURRENT VS 5Y AVG

-57.05%

CURRENT VS 10Y AVG

-64.21%

CURRENT VS 15Y AVG

-67.46%

CURRENT VS 20Y AVG

-67.90%

COR Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Cencora, Inc. (COR)$54.80B2.83%4.08%5.93%6.59%
Becton, Dickinson and Company (BDX)$52.98B7.66%6.14%5.28%4.93%
Regeneron Pharmaceuticals, Inc. (REGN)$63.06B6.30%5.47%4.50%5.46%
Humana Inc. (HUM)$45.53B2.78%5.35%8.81%7.16%
IDEXX Laboratories, Inc. (IDXX)$44.24B2.39%1.86%1.86%1.65%
Agilent Technologies, Inc. (A)$36.67B3.41%3.06%3.54%3.21%
Zoetis Inc. (ZTS)$33.36B6.35%4.09%2.90%2.47%
Centene Corporation (CNC)$32.19B19.65%15.27%12.37%12.29%
Medline Inc. (MDLN)$30.96B5.05%4.78%4.78%4.78%
Cigna Corporation (CI)$78.83B9.73%8.64%9.50%9.22%

Yield Comparison

FCF Yield

2.83%

Earnings Yield

4.63%

Dividend Yield

0.83%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Cencora, Inc. Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Cencora, Inc. Free Cash Flow Yield FAQ

What is the free cash flow yield for Cencora, Inc. (COR)?
The free cash flow yield for COR stock is 2.83%.
Is Cencora, Inc.'s free cash flow yield high or low?
Cencora, Inc.'s free cash flow yield of 2.83% is 57% below its 5-year average of 6.59%, near the low end of its 5-year range (1.57%–10.50%).
What is the TTM average free cash flow yield for Cencora, Inc. (COR)?
The TTM average free cash flow yield for COR stock is 4.08%.
What is the 3Y average free cash flow yield for Cencora, Inc. (COR)?
The 3Y average free cash flow yield for COR stock is 5.93%.
What is the 5Y average free cash flow yield for Cencora, Inc. (COR)?
The 5Y average free cash flow yield for COR stock is 6.59%.
What is the 10Y average free cash flow yield for Cencora, Inc. (COR)?
The 10Y average free cash flow yield for COR stock is 7.91%.
What is the 15Y average free cash flow yield for Cencora, Inc. (COR)?
The 15Y average free cash flow yield for COR stock is 8.70%.
What is the 20Y average free cash flow yield for Cencora, Inc. (COR)?
The 20Y average free cash flow yield for COR stock is 8.82%.

Cencora, Inc. Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-122.83%
2026-06-112.83%
2026-06-102.84%
2026-06-092.85%
2026-06-082.91%
2026-06-052.90%
2026-06-042.95%
2026-06-033.02%
2026-06-023.01%
2026-06-013.01%
2026-05-292.96%
2026-05-282.98%
2026-05-272.99%
2026-05-262.94%
2026-05-222.90%
2026-05-213.00%
2026-05-203.01%
2026-05-193.00%
2026-05-183.05%
2026-05-153.09%
2026-05-143.05%
2026-05-133.12%
2026-05-123.06%
2026-05-113.07%
2026-05-083.05%
2026-05-073.12%
2026-05-063.16%
2026-05-056.04%
2026-05-046.08%
2026-05-016.08%
2026-04-306.00%
2026-04-295.93%
2026-04-285.92%
2026-04-275.96%
2026-04-245.99%
2026-04-235.93%
2026-04-225.99%
2026-04-215.91%
2026-04-205.72%
2026-04-175.64%
2026-04-165.73%
2026-04-155.81%
2026-04-145.77%
2026-04-135.79%
2026-04-105.76%
2026-04-095.73%
2026-04-085.69%
2026-04-075.76%
2026-04-065.75%
2026-04-025.69%
2026-04-015.81%
2026-03-315.88%
2026-03-305.96%
2026-03-275.91%
2026-03-265.81%
2026-03-255.68%
2026-03-245.64%
2026-03-235.76%
2026-03-205.65%
2026-03-195.57%
2026-03-185.68%
2026-03-175.52%
2026-03-165.34%
2026-03-135.28%
2026-03-125.24%
2026-03-115.27%
2026-03-105.24%
2026-03-095.10%
2026-03-065.15%
2026-03-055.14%
2026-03-045.02%
2026-03-034.97%
2026-03-024.96%
2026-02-274.96%
2026-02-265.04%
2026-02-255.09%
2026-02-245.07%
2026-02-235.05%
2026-02-205.12%
2026-02-195.14%
2026-02-185.13%
2026-02-175.13%
2026-02-135.12%
2026-02-125.26%
2026-02-115.05%
2026-02-105.13%
2026-02-095.08%
2026-02-065.14%
2026-02-055.24%
2026-02-045.60%
2026-02-034.57%
2026-02-024.55%
2026-01-304.60%
2026-01-294.70%
2026-01-284.72%
2026-01-274.64%
2026-01-264.65%
2026-01-234.68%
2026-01-224.69%
2026-01-214.70%
2026-01-204.72%
2026-01-164.66%
2026-01-154.66%
2026-01-144.73%
2026-01-134.78%
2026-01-124.83%
2026-01-094.93%
2026-01-084.93%
2026-01-074.86%
2026-01-064.78%
2026-01-054.85%
2026-01-024.88%
2025-12-314.90%
2025-12-304.86%
2025-12-294.86%
2025-12-264.85%
2025-12-244.87%
2025-12-234.86%
2025-12-224.86%
2025-12-194.85%
2025-12-184.86%
2025-12-174.82%
2025-12-164.84%
2025-12-154.72%
2025-12-124.78%
2025-12-114.80%
2025-12-104.85%
2025-12-094.90%
2025-12-084.90%
2025-12-054.87%
2025-12-044.90%
2025-12-034.93%
2025-12-024.72%
2025-12-014.59%
2025-11-284.48%
2025-11-264.49%
2025-11-254.41%
2025-11-241.57%
2025-11-211.60%
2025-11-201.61%
2025-11-191.62%
2025-11-181.62%
2025-11-171.60%
2025-11-141.62%
2025-11-131.60%
2025-11-121.61%
2025-11-111.60%
2025-11-101.60%
2025-11-071.62%
2025-11-061.62%
2025-11-051.65%
2025-11-041.70%
2025-11-031.72%
2025-10-311.73%
2025-10-301.71%
2025-10-291.76%
2025-10-281.74%
2025-10-271.74%
2025-10-241.76%
2025-10-231.78%
2025-10-221.77%
2025-10-211.78%
2025-10-201.79%
2025-10-171.80%
2025-10-161.83%
2025-10-151.83%
2025-10-141.84%
2025-10-131.84%
2025-10-101.84%
2025-10-091.86%
2025-10-081.88%
2025-10-071.89%
2025-10-061.92%
2025-10-031.93%
2025-10-021.90%
2025-10-011.88%
2025-09-301.87%
2025-09-291.90%
2025-09-261.90%
2025-09-251.96%
2025-09-241.90%
2025-09-231.93%
2025-09-222.02%
2025-09-192.02%
2025-09-182.01%
2025-09-172.02%
2025-09-162.02%
2025-09-152.01%
2025-09-121.93%
2025-09-111.93%
2025-09-101.97%
2025-09-091.96%
2025-09-081.96%
2025-09-052.00%
2025-09-042.00%
2025-09-031.98%
2025-09-021.98%
2025-08-292.01%
2025-08-282.02%
2025-08-272.01%
2025-08-262.02%
2025-08-252.03%
2025-08-222.00%
2025-08-211.93%
2025-08-201.93%
2025-08-191.98%
2025-08-182.01%
2025-08-152.00%
2025-08-141.98%
2025-08-132.01%
2025-08-122.02%
2025-08-112.01%
2025-08-082.05%
2025-08-072.10%
2025-08-062.06%
2025-08-056.27%
2025-08-046.24%
2025-08-016.36%
2025-07-316.41%
2025-07-306.28%
2025-07-296.33%
2025-07-286.40%
2025-07-256.31%
2025-07-246.31%
2025-07-236.25%
2025-07-226.25%
2025-07-216.26%
2025-07-186.26%
2025-07-176.23%
2025-07-166.15%
2025-07-156.22%
2025-07-146.17%
2025-07-116.21%
2025-07-106.17%
2025-07-096.11%
2025-07-086.15%
2025-07-076.06%
2025-07-036.19%
2025-07-026.29%
2025-07-016.20%
2025-06-306.11%
2025-06-276.12%
2025-06-266.18%
2025-06-256.27%
2025-06-246.23%
2025-06-236.25%
2025-06-206.24%
2025-06-186.18%
2025-06-176.25%
2025-06-166.27%
2025-06-136.20%
2025-06-126.21%
2025-06-116.39%
2025-06-106.45%
2025-06-096.46%
2025-06-066.34%
2025-06-056.35%
2025-06-046.34%
2025-06-036.29%
2025-06-026.27%

Showing the most recent 260 of 4,850 data points. The chart above shows the full history.

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch